Rx · PZN 08869849
SIMULECT 20 mg powder and solvent for preparation of a solution for injection/infusion
German trade nameSIMULECT 20 mg Pulver und Lösungsmittel zur Herstellung einer Injektions- oder Infusionslösung
According to the data available to us: no longer marketed
No observed availability
0.0out of 10
Storage temperature and transport temperature
Highest known
purchase price (B2B)
We deliver data-driven insights into pharmaceutical price levels and pricing structures across European markets, enabling Most Favoured Nation (MFN) assessments, international price benchmarking, and strategic market access analyses.
SIMULECT 20 mg powder and solvent for preparation of a solution for injection/infusion contains the active ingredient Basiliximab. One pack size is recorded (PZN 08869849). The pharma availability index for German wholesale stands at 0.0 out of 10 over the past 30 days – the pack was therefore without observed availability. According to our records, none of the recorded packs is currently marketed on a regular basis – sources of supply can be checked on request.
According to the data available to us, SIMULECT 20 mg powder and solvent for preparation of a solution for injection/infusion is no longer regularly marketed. We help you identify successor products, remaining stock and import routes.
Request a source of supply